← All trials
NCT04737343
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2021
- Primary completion
- Nov 30, 2024
- Completion date
- Dec 31, 2024
- First posted
- Feb 3, 2021
- Last posted
- Nov 30, 2021
- Enrollment
- 114
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Chinese SLE Treatment And Research GroupLead sponsor
- Chinese Academy of Medical SciencesOverall official - principal investigator
- Anhui Medical UniversityCollaborator
- Fudan UniversityCollaborator
- Zhejiang UniversityCollaborator
- Kunming Medical UniversityCollaborator
- Nanchang UniversityCollaborator
- Inner Mongolia Medical UniversityCollaborator
- Chinese Academy of Medical SciencesReponsible party - principal investigator
- Capital Medical UniversityCollaborator
- Jilin UniversityCollaborator
- Sichuan UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.